Jérôme Declerck

Veran Medical Technologies, Inc. designs, develops, and markets soft tissue equipment. The firm's main focus is assisting physicians in the early diagnosis and treatment of lung cancer. The company was founded by Ben Heavrin, Bruce Lynskey, Jerome R. Edwards, and Evan Austill, Jr. in 2005 and is headquartered in St. Louis, MO.

AEA Technology, Inc. provides RF test equipment. The company's products include VIA bravo, bravo MRI, cellmate EX, and 140-525 analyzers. It also provides equipment to the medical, RFID, telemetry, wireless, aviation, commercial, and two-way radio industries. The company is headquartered in Carlsbad, CA.

Guidance Ltd. is an investment holding company incorporated on 30th July 2002 under the laws of the British Virgin Islands. The issued share capital of Guidance Limited is 10.0%-owned by Cai Qiang, 13.5%-owned by Li Ming, 10.5%-owned by Li Wo Hing, 17.5%-owned by Zhao Tong, 17.5%-owned by Zhao Ying, 18.5%-owned by Zhou Hong and 12.5%-owned by Chan Shut Li, William. It holds 39.66% shareholdings of petrotech.

Dexela Ltd. manufactures and distributes x-ray imaging applications. It offers flat panel CMOS X-ray detectors for a range of applications, including mammography and tomosynthesis, breast CT, dental cone beam CBCT, fluoroscopy, cardiology and angiographic imaging, bone densitometry, scientific instrumentation, and non-destructive testing. The company was founded by Edward Bullard, Martin Stanton and Spencer Gunn in 2005 and is headquartered in London, the United Kingdom.

Mirada Medical Ltd. develops software applications for medical imaging. The firm's software allows images from multiple sources to be combined to provide greater clinical certainty in diagnosis and treatment of cancer. It provides radiology, radiation therapy, tumor board and referring physician solutions. The firm specializes in simplifying technically complex image quantification, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. The company was founded by Mark E. Evans in 1999 and is headquartered in Oxford, the United Kingdom.

Acuitas Medical Ltd. develops magnetic resonance based diagnostic technique. The firm provides its applications for bone disease and liver fibrosis. The company was founded by Peter E. Taylor and Tim James in 2006 and is headquartered in Swansea, the United Kingdom.

Part of Informa Plc, colwiz Ltd. operates an online platform for research management. The company is based in Dublin, Ireland. colwiz was acquired by Informa UK Ltd. on May 31, 2017.

Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom.

Screenpoint Medical BV provides medical services. The company was founded by Michael Brady and Nico Karssemeijer in May 2014 and is headquartered in Nijmegen, the Netherlands.

Elucent Medical, Inc. develops solutions for breast cancer treatment. The firm is pioneering and commercializing a wireless marker tag and detection system that helps locate breast abnormalities and predict margins during surgical excision. The company was founded by Dan van der Weide, Laura G. King, Lee Wilke, Fred T. Lee, Christopher Brace and Elizabeth Burnside and is headquartered in Brookfield, WI.

Guidance Navigation Holdings Ltd. manufactures electrical equipment. The private company is based in Leicester, UK.

Lumeda, Inc. develops develops intraoperative photodynamic therapy for treating lung cancer. The company is headquartered in Rocky Hill, CT.

Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.